tirzepatide cardiovascular outcome ๐ In a large real-world study, was associated with a lower incidence of major outcomes vs semaglutide: ๐ Composite CV outcome: 1.90% vs 2.18% (HR 0.86, p=0.01) โค๏ธ New-onset heart Tirzepatide Linked to Better CV
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours ยท Estimated delivery Aug 25 - Aug 30










:max_bytes(150000):strip_icc()/WhatstheDifferenceBetweenOzempicWegovyandMounjaro-illo-a8f5a23fe4914586b4488472fe15f112.png)












